125 related articles for article (PubMed ID: 8847017)
1. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
Lygidakis NJ; Stringaris K
Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
Lygidakis NJ; Papadopoulou P
Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).
Abdel-Wahab M; El-Shennawy F; Agha S; Ragab E; Fathi O; Sultan A; Elghawalby N; Ezzat F
Hepatogastroenterology; 1999 May; 46 Suppl 1():1293-6. PubMed ID: 10429977
[TBL] [Abstract][Full Text] [Related]
5. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
Lygidakis NJ; Konstantinidou T; Pothoulakis J
Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
[TBL] [Abstract][Full Text] [Related]
6. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative?
Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M
Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631
[TBL] [Abstract][Full Text] [Related]
7. Intrasplenic immunostimulation in malignancies fact or fiction? Present and future.
Lygidakis NJ; Spenzouris N; Dedemadi G; Kyriakou A; Theodorakopoulos M
Hepatogastroenterology; 1998; 45(20):404-10. PubMed ID: 9638414
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of radiation therapy combined with intra-arterial infusion chemotherapy in patients with non-resectable pancreatic cancer].
Ohigashi H; Ishikawa O; Nakamori S; Masutani S; Sasaki Y; Kameyama M; Hiratsuka M; Kabuto T; Furukawa H; Imaoka S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1682-4. PubMed ID: 1530331
[TBL] [Abstract][Full Text] [Related]
9. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma.
Lygidakis NJ; Vlachos L; Raptis S; Sgourakis G; Mourikis D; Kehagias D
Hepatogastroenterology; 1999; 46(28):2229-39. PubMed ID: 10521972
[TBL] [Abstract][Full Text] [Related]
10. Locoregional chemotherapy in pancreatic cancer.
Nazli O; Tansug T; Bozdag AD; Cln N; Kaymak E
Hepatogastroenterology; 1999; 46(25):479-82. PubMed ID: 10228847
[TBL] [Abstract][Full Text] [Related]
11. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
Gebauer T; Ridwelski K; Fahlke J; Lippert H
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
[TBL] [Abstract][Full Text] [Related]
12. Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Lygidakis NJ; Kosmidis P; Ziras N; Parissis J; Kyparidou E
J Interferon Cytokine Res; 1995 May; 15(5):467-72. PubMed ID: 7544232
[TBL] [Abstract][Full Text] [Related]
13. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study.
Lygidakis NJ; Stringaris K; Kokinis K; Lyberopoulos K; Raptis S
Hepatogastroenterology; 1996; 43(7):212-20. PubMed ID: 8682466
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer.
Yamaguchi K; Kobayashi K; Ogura Y; Nakamura K; Nakano K; Mizumoto K; Tanaka M
Hepatogastroenterology; 2005; 52(65):1605-12. PubMed ID: 16201126
[TBL] [Abstract][Full Text] [Related]
15. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients.
van Wagensveld BA; Coene PP; van Gulik TM; Rauws EA; Obertop H; Gouma DJ
Br J Surg; 1997 Oct; 84(10):1402-6. PubMed ID: 9361599
[TBL] [Abstract][Full Text] [Related]
16. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.
Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP
ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872
[TBL] [Abstract][Full Text] [Related]
17. Surgical palliation combined with synchronous therapy in pancreatic carcinoma.
Kahn PJ; Skornick Y; Inbar M; Kaplan O; Chaichik S; Rozin R
Eur J Surg Oncol; 1990 Feb; 16(1):7-11. PubMed ID: 1689679
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
20. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
Wang Z; Chen K; Gong J; Zheng Y; Wang T
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
